Related Experiment Video
Updated: Jan 8, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Pharmacological Enhancement of Integrated Stress Response Confers Protection in Calcific Aortic Valve Disease
Libo Wang1, Xulei Duan1, Huibing Liu1
1Department of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Abstract:
Previous studies have shown that Nox4 activates eIF2α/ATF4 signaling during the integrated stress response (ISR) and protects heart injury. However, their roles in calcific aortic valve disease (CAVD) remain unclear. Here, we show that both ATF4 and Nox4 are up-regulated in porcine aortic valve interstitial cells (AVIC) and in human aortic valves with CAVD. Nox4 knockdown promotes while Nox4 overexpression suppresses CAVD by modulating ISR. Importantly, ISR activators Guanabenz and Sephin1 effectively attenuate AVIC osteoblastic-like differentiation and mitigate CAVD in rabbits and mice, respectively. These findings highlight that pharmacological enhancement of the ISR is a promising therapeutic strategy for CAVD.
Insights
Nox4 and integrated stress response (ISR) signaling are implicated in calcific aortic valve disease (CAVD). Enhancing ISR pharmacologically may offer a novel therapeutic strategy for CAVD.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Integrative Physiology
Background:
- Nox4 and integrated stress response (ISR) signaling (eIF2α/ATF4) protect against heart injury.
- The role of Nox4 and ISR in calcific aortic valve disease (CAVD) is not well understood.
Purpose of the Study:
- To investigate the involvement of Nox4 and ISR in CAVD pathogenesis.
- To explore the therapeutic potential of modulating ISR in CAVD.
Main Methods:
- Examined ATF4 and Nox4 expression in porcine aortic valve interstitial cells (AVICs) and human CAVD tissues.
- Utilized Nox4 knockdown and overexpression models in AVICs.
- Administered ISR activators (Guanabenz, Sephin1) in animal models of CAVD (rabbits, mice).
Main Results:
- ATF4 and Nox4 were upregulated in CAVD.
- Nox4 knockdown exacerbated CAVD, while overexpression suppressed it by modulating ISR.
- ISR activators attenuated AVIC osteoblastic differentiation and mitigated CAVD in vivo.
Conclusions:
- Nox4 and ISR play critical roles in CAVD development.
- Pharmacological enhancement of ISR represents a promising therapeutic avenue for CAVD.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Mitral Stenosis III: Medical Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

